Skip to main content

Subglottic Stenosis clinical trials at UCSF
1 in progress, 1 open to new patients

  • Study of Mitomycin-C Application in Laryngotracheal Stenosis

    open to eligible people ages 18 years and up

    This is a randomized, prospective, double-blind, placebo-controlled clinical trial of the use of mitomycin-C topical application as an adjunctive treatment in the endoscopic surgical treatment of patients with laryngotracheal stenosis. We hypothesize that the use of mitomycin-C improves patient outcome in the endoscopic surgical treatment of laryngotracheal stenosis.

    San Francisco, California